Top compounds associated with response to SERGEF


Feature Type Standardized
Nominal ANOVA
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.17 2e-06
mRNA BRD-K94991378 CTRPv2 pan-cancer AAC 0.17 2e-05
mRNA AZD0530 CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.11 9e-05
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA FK866 GDSC1000 pan-cancer AAC 0.12 0.0001
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0002
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.0004
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.12 0.0005
Download CSV